Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Talwani

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|March 13, 2020
Doravirine: a new non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infectionR Talwani, Z Temesgen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2000
Tuberculous peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: case report and reviewR Talwani, J A Horvath
Drugs of Today (Barcelona, Spain : 1998)|February 14, 2014
Dolutegravir, an HIV integrase inhibitor for the treatment of HIV infectionZ Temesgen, R Talwani, S A Rizza
Drugs of Today (Barcelona, Spain : 1998)|July 2, 2014
Sofosbuvir for the treatment of chronic hepatitis C virus infectionZ Temesgen, R Talwani, S A Rizza
Chest|December 24, 1997
Penicillin dosing for pneumococcal pneumoniaC S Bryan, R Talwani, M S Stinson
Drugs of Today (Barcelona, Spain : 1998)|December 8, 2011
Telaprevir: looking for a sustained virologic response in hepatitis C virus infectionV Nehra, S A Rizza, R Talwani, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 15, 2011
BoceprevirS A Rizza, R Talwani, V Nehra, et al.
Drugs of Today (Barcelona, Spain : 1998)|February 14, 2014
Simeprevir: a macrocyclic HCV protease inhibitorR Talwani, E L Heil, B L Gilliam, et al.
Drugs of Today (Barcelona, Spain : 1998)|March 31, 2012
Current status of treatment for chronic hepatitis C virus infectionR Talwani, B L Gilliam, S A Rizza, et al.
Journal of Viral Hepatitis|November 15, 2013
Predictors of early treatment discontinuation in a cohort of patients treated with boceprevir-based therapy for hepatitis C infectionA Majid, J McAninch, D J Morgan, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Drugs of Today (Barcelona, Spain : 1998)|March 13, 2020
Doravirine: a new non-nucleoside reverse transcriptase inhibitor for the treatment of HIV infectionR Talwani, Z Temesgen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 29, 2000
Tuberculous peritonitis in patients undergoing continuous ambulatory peritoneal dialysis: case report and reviewR Talwani, J A Horvath
Drugs of Today (Barcelona, Spain : 1998)|February 14, 2014
Dolutegravir, an HIV integrase inhibitor for the treatment of HIV infectionZ Temesgen, R Talwani, S A Rizza
Drugs of Today (Barcelona, Spain : 1998)|July 2, 2014
Sofosbuvir for the treatment of chronic hepatitis C virus infectionZ Temesgen, R Talwani, S A Rizza
Chest|December 24, 1997
Penicillin dosing for pneumococcal pneumoniaC S Bryan, R Talwani, M S Stinson
Drugs of Today (Barcelona, Spain : 1998)|December 8, 2011
Telaprevir: looking for a sustained virologic response in hepatitis C virus infectionV Nehra, S A Rizza, R Talwani, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 15, 2011
BoceprevirS A Rizza, R Talwani, V Nehra, et al.
Drugs of Today (Barcelona, Spain : 1998)|February 14, 2014
Simeprevir: a macrocyclic HCV protease inhibitorR Talwani, E L Heil, B L Gilliam, et al.
Drugs of Today (Barcelona, Spain : 1998)|March 31, 2012
Current status of treatment for chronic hepatitis C virus infectionR Talwani, B L Gilliam, S A Rizza, et al.
Journal of Viral Hepatitis|November 15, 2013
Predictors of early treatment discontinuation in a cohort of patients treated with boceprevir-based therapy for hepatitis C infectionA Majid, J McAninch, D J Morgan, et al.
Pageof 2